NCT04728750

Brief Summary

The present study describes a 32-year-old female patient, in whom a preoperative imaging diagnosis confirmed a mass in the junction of the body and tail of the pancreas. Based on the anamnesis, on the preoperative diagnosis, and on the general status of the patient, the decision was made to performed laparoscopic enucleation of the pancreatic tumor. The operation and postoperative recovery passed without complications. A minimally invasive surgical approach should be applied whenever the dimensions and the localization of the tumor permits it, bearing in mind all the benefits and advantages that this surgical technique has to offer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 2, 2021

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

January 21, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 28, 2021

Completed
Last Updated

January 28, 2021

Status Verified

January 1, 2021

Enrollment Period

1 month

First QC Date

January 21, 2021

Last Update Submit

January 25, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Complete enucleation of a tumor in the pancreas

    Performance of a laparoscopic enucleation of a tumor in the pancreas, and compared it with a conventional approach

    December 2020

Interventions

Enucleation of a tumor in the pancreas is feasible and safe, as it offers a minimally invasive approach, and morbidities are fewer than open or conventional approach

Eligibility Criteria

Age18 Years - 100 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with a diagnosed pancreatic tumor by image study.

You may qualify if:

  • Patients with benign tumor of the pancreas
  • Patients with a size tumor of less than 3 cm on the pancreas

You may not qualify if:

  • Patients with a size tumor greater than 3 cm on the pancreas
  • Malignant tumors of the pancreas

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Escuela Nacional de Medicina, Tecnologico de Monterrey

Monterrey, Nuevo León, 76140, Mexico

Location

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

January 21, 2021

First Posted

January 28, 2021

Study Start

December 1, 2020

Primary Completion

January 1, 2021

Study Completion

January 2, 2021

Last Updated

January 28, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations